TP53 and B-cell chronic lymphocytic leukemia: A recent study published by Rossi et al demonstrated that ultra-deep-NGS significantly improved the detection of TP53 genetic defects in B-CLL allowing the identification of small TP53 mutated subclones among patients that would be otherwise considered wild type for the TP53 gene according to Sanger sequencing [27].